BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 26041887)

  • 21. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.
    Narla G; DiFeo A; Yao S; Banno A; Hod E; Reeves HL; Qiao RF; Camacho-Vanegas O; Levine A; Kirschenbaum A; Chan AM; Friedman SL; Martignetti JA
    Cancer Res; 2005 Jul; 65(13):5761-8. PubMed ID: 15994951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
    Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model.
    Kim SJ; Johnson M; Koterba K; Herynk MH; Uehara H; Gallick GE
    Clin Cancer Res; 2003 Nov; 9(14):5161-70. PubMed ID: 14613995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vav3-rac1 signaling regulates prostate cancer metastasis with elevated Vav3 expression correlating with prostate cancer progression and posttreatment recurrence.
    Lin KT; Gong J; Li CF; Jang TH; Chen WL; Chen HJ; Wang LH
    Cancer Res; 2012 Jun; 72(12):3000-9. PubMed ID: 22659453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
    Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
    Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein kinase A (PKA) pathway is functionally linked to androgen receptor (AR) in the progression of prostate cancer.
    Sarwar M; Sandberg S; Abrahamsson PA; Persson JL
    Urol Oncol; 2014 Jan; 32(1):25.e1-12. PubMed ID: 23410945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF).
    Ling MT; Lau TC; Zhou C; Chua CW; Kwok WK; Wang Q; Wang X; Wong YC
    Carcinogenesis; 2005 Oct; 26(10):1668-76. PubMed ID: 15905202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the human cachexia-associated protein (HCAP) in prostate cancer and in a prostate cancer animal model of cachexia.
    Wang Z; Corey E; Hass GM; Higano CS; True LD; Wallace D; Tisdale MJ; Vessella RL
    Int J Cancer; 2003 May; 105(1):123-9. PubMed ID: 12672042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model.
    Gabril MY; Onita T; Ji PG; Sakai H; Chan FL; Koropatnick J; Chin JL; Moussa M; Xuan JW
    Gene Ther; 2002 Dec; 9(23):1589-99. PubMed ID: 12424611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transfected neu oncogene induces human prostate cancer metastasis.
    Zhau HY; Zhou J; Symmans WF; Chen BQ; Chang SM; Sikes RA; Chung LW
    Prostate; 1996 Feb; 28(2):73-83. PubMed ID: 8604395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing of S100A4, a metastasis-associated protein, in endothelial cells inhibits tumor angiogenesis and growth.
    Ochiya T; Takenaga K; Endo H
    Angiogenesis; 2014 Jan; 17(1):17-26. PubMed ID: 23929008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo.
    Shukeir N; Pakneshan P; Chen G; Szyf M; Rabbani SA
    Cancer Res; 2006 Sep; 66(18):9202-10. PubMed ID: 16982764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombin receptor expression is upregulated in prostate cancer.
    Kaushal V; Kohli M; Dennis RA; Siegel ER; Chiles WW; Mukunyadzi P
    Prostate; 2006 Feb; 66(3):273-82. PubMed ID: 16245281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor.
    Balbay MD; Pettaway CA; Kuniyasu H; Inoue K; Ramirez E; Li E; Fidler IJ; Dinney CP
    Clin Cancer Res; 1999 Apr; 5(4):783-9. PubMed ID: 10213213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential clinical relevance of Eph receptors and ephrin ligands expressed in prostate carcinoma cell lines.
    Fox BP; Tabone CJ; Kandpal RP
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1263-72. PubMed ID: 16516143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-Time GFP Intravital Imaging of the Differences in Cellular and Angiogenic Behavior of Subcutaneous and Orthotopic Nude-Mouse Models of Human PC-3 Prostate Cancer.
    Zhang Y; Toneri M; Ma H; Yang Z; Bouvet M; Goto Y; Seki N; Hoffman RM
    J Cell Biochem; 2016 Nov; 117(11):2546-51. PubMed ID: 27012365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SUMO-specific protease 1 promotes prostate cancer progression and metastasis.
    Wang Q; Xia N; Li T; Xu Y; Zou Y; Zuo Y; Fan Q; Bawa-Khalfe T; Yeh ET; Cheng J
    Oncogene; 2013 May; 32(19):2493-8. PubMed ID: 22733136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human prostate cancer in a clinically relevant xenograft mouse model: identification of β(1,6)-branched oligosaccharides as a marker of tumor progression.
    Lange T; Ullrich S; Müller I; Nentwich MF; Stübke K; Feldhaus S; Knies C; Hellwinkel OJ; Vessella RL; Abramjuk C; Anders M; Schröder-Schwarz J; Schlomm T; Huland H; Sauter G; Schumacher U
    Clin Cancer Res; 2012 Mar; 18(5):1364-73. PubMed ID: 22261809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of matriptase by overexpression of bikunin attenuates cell invasion in prostate carcinoma cells.
    Tsui KH; Chang PL; Feng TH; Chung LC; Hsu SY; Juang HH
    Anticancer Res; 2008; 28(4A):1977-83. PubMed ID: 18649735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta.
    Dong Z; Greene G; Pettaway C; Dinney CP; Eue I; Lu W; Bucana CD; Balbay MD; Bielenberg D; Fidler IJ
    Cancer Res; 1999 Feb; 59(4):872-9. PubMed ID: 10029078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.